![main_logo](user/core/view/reaction/header/303/inc/images/logo.png)
Yong Jae Lee, Myong Cheol Lim, Byoung-Gie Kim, Natalie YL Ngoi, Chel Hun Choi, Sang-Yoon Park, David SP Tan, Yunjung Go and Jung-Yun Lee
A single-arm phase II study of olaparib maintenance with pembrolizumab and bevacizumab in BRCA non-mutated patients with platinum-sensitive recurrent ovarian cancer (OPEB-01)
Yoo-Na Kim, Boram Park, Jae Weon Kim, Byoung Gie Kim, Sang Wun Kim, Hee Seung Kim, Chel Hun Choi, Myong Cheol Lim, Natalie YL Ngoi, David SP Tan & Jung-Yun Lee
Triplet maintenance therapy of olaparib, pembrolizumab and bevacizumab in women with BRCA wild-type, platinum-sensitive recurrent ovarian cancer: the multicenter, single-arm phase II study OPEB-01/APGOT-OV4